The NMDA Receptor as a Therapeutic Target in Major Depressive Disorder

E-ISSN： 1996-3181|6|2|101-115

ISSN： 1871-5273

Source： CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol.6, Iss.2, 2007-01, pp. : 101-115

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapeutic Modulation of Glutamate Receptors in Major Depressive Disorder

Current Neuropharmacology, Vol. 15, Iss. 1, 2016-12 ,pp. : 57-70

Bentham Science Publishers

Access to resources Recommend Favorite

Corticotropin releasing factor receptor antagonists for major depressive disorder

By Paez-Pereda Marcelo Hausch Felix Holsboer Florian

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 4, 2011-04 ,pp. : 519-535

Informa Healthcare

Access to resources Recommend Favorite

Vilazodone: In Major Depressive Disorder

By Frampton James E.

CNS Drugs, Vol. 25, Iss. 7, 2011-07 ,pp. : 615-627

Adis International

Access to resources Recommend Favorite

Aripiprazole: In Major Depressive Disorder

By Weber Juliane Lyseng-Williamson Katherine A. Scott Lesley J.

CNS Drugs, Vol. 22, Iss. 10, 2008-01 ,pp. : 807-813

Adis International

Access to resources Recommend Favorite

Agomelatine for the treatment of major depressive disorder

By Carney Regina M Shelton Richard C

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 15, 2011-10 ,pp. : 2411-2419

Informa Healthcare

Access to resources Recommend Favorite